<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-95 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-95</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-95</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-1.html">extraction-schema-1</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <p><strong>Paper ID:</strong> paper-81b2a6652a8fde71493fde504f0e7da1b55abf89</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/81b2a6652a8fde71493fde504f0e7da1b55abf89" target="_blank">Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</a></p>
                <p><strong>Paper Venue:</strong> Science</p>
                <p><strong>Paper TL;DR:</strong> 25 spatially distinct regions from seven operable NSCLCs were sequenced and found evidence of branched evolution, with driver mutations arising before and after subclonal diversification, and pronounced intratumor heterogeneity in copy number alterations, translocations, and mutations associated with APOBEC cytidine deaminase activity.</p>
                <p><strong>Cost:</strong> 0.022</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e95.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e95.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR L858R</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Epidermal growth factor receptor L858R</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A recurrent point mutation (Leu858Arg) in EGFR observed in this study in two spatially separate tumors (patient L003), consistent with a known oncogenic EGFR substitution.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>EGFR L858R</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>EGFR (RTK)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion whole-exome sequencing (M-seq WES); comparative regional mutation presence</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td>Observed in two anatomically separate tumors from patient L003; authors infer independent clonal origins with parallel evolution of this recurrent event.</td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-exome sequencing (M-seq WES)</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e95.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR amplification</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR focal amplification (chr7p11.2)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Focal copy-number amplification of EGFR observed ubiquitously across regions of tumor L001.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>EGFR amplification (chr7p11.2)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>amplification / copy number alteration</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>EGFR (RTK)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>copy number estimation from M-seq WES/WGS; integer copy number profiling</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-exome sequencing / whole-genome sequencing with copy-number analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e95.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>BRAF G469A</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>BRAF glycine 469 to alanine (G469A)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>An activating BRAF point mutation (G469A) present in all regions of tumor L008, noted by the authors as an activating event.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>BRAF G469A</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>BRAF (RAF family kinase)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion sequencing identifying truncal mutation</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td>Labeled in the paper as an activating BRAF mutation (authors annotate functional status based on prior knowledge), but no in-study functional assays reported.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Authors discuss that a biopsy showing only BRAF G469A would suggest BRAF inhibitor therapy; spatial heterogeneity (co-occurring PIK3CA in one region) could influence response.</td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-exome sequencing (M-seq WES)</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e95.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PIK3CA E542K</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>PIK3CA glutamate 542 to lysine (E542K)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>An activating PIK3CA hotspot point mutation (E542K) detected only in region R3 of tumor L008 (regional/heterogeneous event).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>PIK3CA E542K</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>PIK3CA (PI3K pathway)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion whole-exome sequencing identifying region-private activating mutation</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td>Annotated as activating in the paper (no functional assays reported in this study).</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Authors note that presence of PIK3CA E542K in region R3 could suggest PI3K/mTOR pathway targeted therapy and could confer resistance to single-agent BRAF inhibition in that region.</td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-exome sequencing (M-seq WES)</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e95.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>TP53 (truncal)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Tumor protein p53 (TP53) truncal mutations</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>TP53 truncal point mutation(s) observed among early (truncal) mutations in tumor L002 and noted as an early driver in study tumors.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>TP53 mutation(s) (truncal)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation / loss-of-function (inferred)</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>TP53 (tumor suppressor)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion whole-genome / whole-exome sequencing; temporal placement as truncal</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-genome sequencing (M-seq WGS) / whole-exome sequencing (M-seq WES)</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e95.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>TGFBR1 (APOBEC context)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Transforming growth factor beta receptor 1 (TGFBR1) mutation in APOBEC context</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A branch (subclonal, region-private) mutation in TGFBR1 found in the LUAD region of L002 that occurs in an APOBEC mutational context and is implicated as a subclonal driver.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>TGFBR1 point mutation (APOBEC-context)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation (APOBEC-associated)</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>TGFBR1 (TGF-beta pathway)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion whole-genome sequencing; trinucleotide context analysis showing APOBEC signature</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td>Occurred specifically in LUAD region of L002 and within APOBEC-enriched subclone.</td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-genome sequencing with mutational-signature analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e95.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PTPRD (APOBEC context)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Protein tyrosine phosphatase, receptor type D (PTPRD) mutation in APOBEC context</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A subclonal mutation in PTPRD detected in the LUAD region of L002 occurring in an APOBEC mutation context, implicated as a potential driver of subclonal expansion.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>PTPRD point mutation (APOBEC-context)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation (APOBEC-associated)</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>PTPRD (protein tyrosine phosphatase tumor suppressor)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion WGS; mutational-signature contextualization (APOBEC enrichment in branch)</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td>Subclonal and regionally restricted to LUAD branch in L002.</td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-genome sequencing; trinucleotide-context analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e95.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>AKAP9 (APOBEC context)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>A-kinase anchoring protein 9 (AKAP9) mutation in APOBEC context</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>An APOBEC-context branch mutation in AKAP9 reported among subclonal driver events in study tumors.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>AKAP9 point mutation (APOBEC-context)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation (APOBEC-associated)</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>AKAP9</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion sequencing and mutational-signature analysis</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion WES/WGS; trinucleotide-context APOBEC analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.8">
                <h3 class="extraction-instance">Extracted Data Instance 8 (e95.8)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EP300 (APOBEC context)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>E1A binding protein p300 (EP300) mutation in APOBEC context</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>EP300 is reported to harbor branch mutations in an APOBEC mutational context in the cohort, representing potential subclonal driver events.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>EP300 point mutation (APOBEC-context)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation (APOBEC-associated)</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>EP300 (chromatin modifier)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion WES/WGS; mutational-signature analysis</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion WES/WGS; APOBEC signature analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.9">
                <h3 class="extraction-instance">Extracted Data Instance 9 (e95.9)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>FAT1 (stop-gain)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>FAT atypical cadherin 1 (FAT1) stop-gain mutation</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A stop-gain truncating mutation in FAT1 identified on the LUSC branch of tumor L002, representing a branch-specific tumor-suppressor alteration.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>FAT1 stop-gain mutation</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>nonsense / truncating mutation</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>FAT1 (candidate tumor suppressor)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion WGS identifying branch-private truncating mutation</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td>Branch-specific to LUSC region in adenosquamous tumor L002.</td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-genome sequencing (M-seq WGS)</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.10">
                <h3 class="extraction-instance">Extracted Data Instance 10 (e95.10)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>NF1 disruption</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Neurofibromin 1 (NF1) disrupted by clustered translocations</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>NF1 tumor-suppressor gene was disrupted by clustered translocations (chains of translocations) in tumor L008, inferred from M-seq WGS structural variant analysis.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>NF1 disruption by translocation (structural variant)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>structural variant / gene disruption</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>NF1 (negative regulator of RAS pathway)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>high-coverage M-seq WGS structural variant detection; breakpoint analysis</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td>Inferred loss/disruption of tumor suppressor due to structural rearrangement; no functional assay reported in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-genome sequencing (M-seq WGS); structural variant analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.11">
                <h3 class="extraction-instance">Extracted Data Instance 11 (e95.11)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>FANCM disruption</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>FANCM disrupted by clustered translocations</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>FANCM was disrupted by chains of translocations in tumor L008, detected by high-coverage WGS and suggested to result from chromoanagenesis.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>FANCM disruption by translocation (structural variant)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>structural variant / gene disruption</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>FANCM (DNA repair / genome stability)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>M-seq WGS structural variant calling; clustered breakpoints forming translocation chains</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td>Disruption implies loss of DNA repair function; no direct functional assays reported here.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>High-coverage multiregion whole-genome sequencing (M-seq WGS); breakpoint analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.12">
                <h3 class="extraction-instance">Extracted Data Instance 12 (e95.12)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>CDKN2A deletion</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>CDKN2A focal deletion (chr9p21.3)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Copy-number loss of the CDKN2A locus observed as a recurrent deletion in some tumors and ubiquitously in L001.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>CDKN2A deletion (chr9p21.3)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>deletion / copy number alteration</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>CDKN2A (cell cycle regulator)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>copy-number analysis from M-seq WES/WGS</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion WES/WGS copy-number estimation</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.13">
                <h3 class="extraction-instance">Extracted Data Instance 13 (e95.13)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PTEN deletion</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>PTEN focal deletion (chr10q23.31)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Copy-number loss of PTEN observed in some tumor regions (ubiquitous in L001; heterogeneous in L008).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>PTEN deletion (chr10q23.31)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>deletion / copy number alteration</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>PTEN (PI3K pathway regulator / tumor suppressor)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>copy number estimation from M-seq WES/WGS</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion WES/WGS copy-number analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.14">
                <h3 class="extraction-instance">Extracted Data Instance 14 (e95.14)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PAX7 mutation (regional)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>PAX7 mutation (regionally heterogeneous due to copy-number loss)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A PAX7 mutation noted to become regionally heterogeneous because of regional copy-number loss in the lymph node of L001.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>PAX7 point mutation (regional heterogeneity due to copy-number loss)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation with copy-number modulation</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>PAX7</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion WES showing truncal then heterogeneous status due to copy-number loss</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-exome sequencing with copy-number analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.15">
                <h3 class="extraction-instance">Extracted Data Instance 15 (e95.15)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>CHD8</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Chromodomain helicase DNA binding protein 8 (CHD8) mutation</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>CHD8 mutation observed among early/truncal mutations in tumor L002, reported as part of the early mutational repertoire.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>CHD8 point mutation (truncal)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutation</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>CHD8 (chromatin remodeling)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion WGS/WES identifying truncal mutation</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion sequencing (WGS/WES)</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.16">
                <h3 class="extraction-instance">Extracted Data Instance 16 (e95.16)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>ZFHX4, ARHGAP35</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Zinc finger homeobox 4 (ZFHX4) and Rho GTPase activating protein 35 (ARHGAP35) mutations</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Branch mutations in ZFHX4 and ARHGAP35 identified in the LUAD region of tumor L002 among region-specific driver candidates.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>ZFHX4 point mutation; ARHGAP35 point mutation</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>point mutations</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>ZFHX4; ARHGAP35</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>multiregion WGS/WES identifying region-private mutations</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-genome / whole-exome sequencing</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.17">
                <h3 class="extraction-instance">Extracted Data Instance 17 (e95.17)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Genome doubling (WGD)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Whole-genome doubling (genome-doubling event)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Whole-genome-doubling events were detected in four tumors (three occurring truncally before diversification), indicating an early chromosomal event occurring after acquisition of driver mutations in some cases.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>Whole-genome doubling (WGD)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>large-scale copy-number / ploidy change</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>genome-wide event (chromosomal instability)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>integer copy-number estimation across regions; temporal placement relative to truncal mutations</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td>Inferred to accelerate subsequent genome evolution; no direct functional assays in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td>Inferred to have occurred before clinical detection in some former smokers, suggesting prolonged latency.</td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Authors discuss that genome doubling and ensuing chromosomal instability may complicate targeting truncal drivers and impact drug resistance.</td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion whole-exome and whole-genome sequencing with copy-number/ploidy analysis</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.18">
                <h3 class="extraction-instance">Extracted Data Instance 18 (e95.18)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Chromosomal instability (CIN)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Chromosomal instability and structural rearrangements (CIN)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Extensive intratumor heterogeneity of copy-number alterations, structural variants, and chained translocations indicative of chromosomal instability and punctuated events (chromoanagenesis) were observed across tumors.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>Chromosomal instability (structural variants, copy-number heterogeneity, translocation chains)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>structural variation / copy-number alteration / genome rearrangement</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>genome-wide chromosomal instability processes</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>M-seq WGS and WES; structural variant calling; FISH validation of numerical chromosomal diversity</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td>Linked conceptually to subclonal competition and potential drug resistance.</td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Authors suggest CIN may limit effectiveness of targeting truncal drivers and contribute to resistance.</td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions)</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion WGS/WES, structural-variant analysis, FISH</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e95.19">
                <h3 class="extraction-instance">Extracted Data Instance 19 (e95.19)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>APOBEC-associated mutagenesis</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>APOBEC cytidine deaminaseassociated mutational process</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>An endogenous mutational process (C>T and C>G at TpC) that is enriched in late/subclonal mutations and implicated in generating subclonal driver mutations in LUAD regions in this cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Spatial and temporal diversity in genomic instability processes defines lung cancer evolution</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>driver_alteration</strong></td>
                            <td>APOBEC-associated mutational signature (C>T and C>G at TpC; generating subclonal driver mutations)</td>
                        </tr>
                        <tr>
                            <td><strong>alteration_type</strong></td>
                            <td>mutational process / signature</td>
                        </tr>
                        <tr>
                            <td><strong>gene_or_pathway</strong></td>
                            <td>APOBEC family (APOBEC3B expression correlated in regions)</td>
                        </tr>
                        <tr>
                            <td><strong>is_rtk_ras_raf_pathway</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_luad</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>frequency_in_driver_negative</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>evidence_type</strong></td>
                            <td>trinucleotide-context mutational-signature analysis across trunk vs branch; regional APOBEC3B mRNA expression measurement</td>
                        </tr>
                        <tr>
                            <td><strong>functional_evidence</strong></td>
                            <td>Enrichment of APOBEC-context mutations among branch driver events suggests functional contribution to subclonal expansion; no direct mechanistic assays in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_associations</strong></td>
                            <td>APOBEC enrichment increased over time (late mutations) and showed spatial heterogeneity; more pronounced in LUAD than LUSC in this dataset.</td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Authors note APOBEC-driven subclonal diversification may complicate therapy targeting and contribute to emergence of resistance.</td>
                        </tr>
                        <tr>
                            <td><strong>study_cohort_size</strong></td>
                            <td>7 tumors (25 regions) and TCGA validation cohorts referenced</td>
                        </tr>
                        <tr>
                            <td><strong>detection_method</strong></td>
                            <td>Multiregion WES/WGS with trinucleotide-context mutational-signature analysis; mRNA expression (APOBEC3B) assayed</td>
                        </tr>
                        <tr>
                            <td><strong>novel_or_rare</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Spatial and temporal diversity in genomic instability processes defines lung cancer evolution', 'publication_date_yy_mm': '2014-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <p class="empty-note">No potentially relevant new papers extracted.</p>
        </div>

        </div>

    </div>
</body>
</html>